According to the results of Salvatori et al. (2009) the molecular and biochemical differences of troponin T and the insulin receptor between DM1 and DM2 due to different translational patterns and distribution patterns might partially explain the apparent differences on their clinical phenotypes. This evidence concerns the gene INSR and myotonic dystrophy type 1.